Altos Labs
PrivateLast Round
VC Round
Jan 19, 2022
Est. Valuation
$6.33B
Company Overview
Altos Labs operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a VC Round in January 2022.
Altos Labs is a biotechnology company focused on cellular rejuvenation programming to develop innovative medical solutions that aim to restore cell health and resilience, allowing clients to reverse disease, injury, and disabilities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altos Labs Comparables
Compare Altos Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewLimit | 87% | |
| Retro | 86% | |
| Life Biosciences | 81% |
For institutional investors. Book with your work email.
Altos Labs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Altos Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | VC Round |
| Bezos Expeditions | VC Round |
| ARCH Venture Partners | VC Round |
| General Catalyst | VC Round |
| Foresite Capital | VC Round |
| Mubadala Capital | VC Round |
| Kleiner Perkins | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Virtual Cell team won the Generalist prize in the ARC Virtual Cell Challenge.
- Jan 1, 2026
Ranked for the second consecutive year on the Forbes 2026 list.
For institutional investors. Book with your work email.
Altos Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Altos Labs's valuation, stock price, and market status.
Is Altos Labs a public or private company?
Altos Labs is a private company.
What is the current stock price of Altos Labs?
Altos Labs is a private company, so its shares have no public market price. Caplight tracks Altos Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Altos Labs worth (valuation)?
Altos Labs's valuation is estimated at $6.3B based on funding round data.
Can I buy Altos Labs stock?
Altos Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Altos Labs's last funding round?
Altos Labs's most recent funding round was VC Round on January 19, 2022.
Who are the main investors in Altos Labs?
Key investors in Altos Labs include Altitude Life Science Ventures, Bezos Expeditions, ARCH Venture Partners, General Catalyst, Foresite Capital.
Will Altos Labs IPO soon?
No public IPO plans have been announced for Altos Labs.
How can I track Altos Labs secondary market activity?
Caplight tracks bids, offers, and trades in Altos Labs's shares on secondary markets.